Dipeptidyl peptidase 4 inhibitors

277 Pill - brown round, 10mm

Generic Name: sitagliptin

Pill with imprint 277 is Brown, Round and has been identified as Januvia 100 mg. It is supplied by Merck & Company Inc.

Januvia is used in the treatment of Diabetes, Type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Januvia (Sitagliptin [ si-ta-glip-tin ])-277-100 mg-Brown-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-277-100 mg-Brown-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-277-100 mg-Brown-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-277-100 mg-Brown-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-277-100 mg-Brown-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-277-100 mg-Brown-Round

Januvia
Generic Name: sitagliptin [ si-ta-glip-tin ]
Imprint: 277
Strength: 100 mg
Color: Brown
Size: 10.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Dipeptidyl peptidase 4 inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Calcium phosphate dibasic anhydrous, Croscarmellose sodium, Magnesium stearate, Microcrystalline cellulose, Ferric oxide red, Sodium stearyl fumarate, Magnesium silicate, Titanium dioxide, Ferric oxide yellow,
Latest News
Related Drugs